Amazon Pharmacy and One Medical have launched a pilot program to enhance Amazon's hybrid primary care services, specifically focusing on elderly patients managing multiple chronic conditions. The initiative, initiated in the fourth quarter of 2023, enables One Medical providers to request medication consultations for patients with intricate medication regimens. The consultations involve the review of medication interactions and potential de-prescribing. Additionally, patients can utilise a user-friendly messaging platform to communicate with healthcare professionals, aiming to facilitate quick and straightforward consultations.
The pilot program, if successful, holds the potential for Amazon to expand its hybrid primary care offerings and evolve the initiative into a more comprehensive outpatient care service. This expansion could influence other healthcare providers to introduce similar services. Amazon's acquisition of One Medical in 2022, valued at nearly $4 billion, underlines the company's strategic positioning as a significant player in the dynamic intersection of healthcare and technology. Amazon has been actively pursuing various health-related initiatives, including Health Condition Programs and investments in AI research and global health equity initiatives, further solidifying its commitment to shaping the future of healthcare.
In its broader healthcare strategy, Amazon has recently debuted Health Condition Programs in collaboration with Omada Health, aiming to provide customers access to digital health benefits for managing chronic conditions like diabetes, prediabetes, and high blood pressure. The company's engagement in AI research through the AWS Generative AI Innovation Center and a $20 million investment in a global cloud-based health equity initiative highlights its multifaceted approach to advancing healthcare technologies and services.
Click here to read the original news story.